FBR Capital analyst Vernon Bernardino weighed in on Novavax (NASDAQ: NVAX), which is down 5% mid-day on investors concerns after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE